search
Back to results

Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa ((A16))

Primary Purpose

Retinitis Pigmentosa

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Argus 16 Retinal Stimulation System
Sponsored by
Second Sight Medical Products
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Retinitis Pigmentosa

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Confirmed history of retinal degenerative disease in the worse seeing eye with remaining vision no better than light perception. The fellow eye can have any visual acuity but must have better vision than the eye that will have the surgery. History of former useful form vision in worse-seeing eye Acceptable ability to describe visual percepts Age eighteen (18) or older Exclusion Criteria: History of glaucoma Optic neuropathy or other confirmed damage to optic nerve or visual cortical damage Presence of communicable disease/infection Pregnancy History of claustrophobia Inconsistent flash detection thresholds Any other diseases that can effect the function of the retina Subjects with a Beck Depression Inventory Interpretation score of >30 and subsequent diagnosis of depression by a psychiatrist. Corneal degeneration

Sites / Locations

  • Doheny Eye Institute

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

single arm study

Arm Description

Argus 16 Retinal Stimulation System-single arm study.

Outcomes

Primary Outcome Measures

Number of Adverse Events From 2 Weeks Post-op Until the End of the Study
All adverse events are collected as a result of chronic electrical stimulation and/or surgical complications.

Secondary Outcome Measures

Full Information

First Posted
January 17, 2006
Last Updated
April 10, 2023
Sponsor
Second Sight Medical Products
search

1. Study Identification

Unique Protocol Identification Number
NCT00279500
Brief Title
Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa
Acronym
(A16)
Official Title
Chronic Retinal Electrodes to Provide Electrical Stimulation of the Retina to Elicit Visual Percepts in Blind Subjects
Study Type
Interventional

2. Study Status

Record Verification Date
April 2018
Overall Recruitment Status
Completed
Study Start Date
February 27, 2002 (Actual)
Primary Completion Date
December 31, 2014 (Actual)
Study Completion Date
December 31, 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Second Sight Medical Products

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The objective of this study is to evaluate the safety and efficacy of the retinal stimulation system by evaluating the data after chronic implantation.
Detailed Description
The chronic retinal stimulation system is an implantable electronic device designed to provide electrical stimulation of the retina in order to elicit visual percepts in blind subjects. This chronic feasibility study will evaluate the ability of subjects to resolve multiple percepts and patterns under various stimulus conditions and optimize the effectiveness of electrical stimulus parameters with an initial chronic design.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Retinitis Pigmentosa

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Subjects with a confirmed history of advanced retinal degenerative disease and meeting the inclusion criteria listed will be considered as eligible participants in the study. Subjects who have a condition listed in the exclusion criteria will not be allowed to participate in the study. Eligible subjects with the above diagnoses will be recruited from the Doheny Eye Institute at the University of Southern California. Additionally, new subjects encountered in the clinic who fulfill the inclusion criteria will also be eligible to participate. Upon meeting the entry criteria, all subjects must sign an Informed Consent prior to enrollment in the study. Since the subjects are blind, an individual not associated with this study must read the informed consent to the subject. This person must sign the consent form as a witness to the informed consent process.
Masking
None (Open Label)
Allocation
N/A
Enrollment
6 (Actual)

8. Arms, Groups, and Interventions

Arm Title
single arm study
Arm Type
Experimental
Arm Description
Argus 16 Retinal Stimulation System-single arm study.
Intervention Type
Device
Intervention Name(s)
Argus 16 Retinal Stimulation System
Intervention Description
The chronic retinal stimulation system is an implantable electronic device designed to provide electrical stimulation of the retina in order to elicit visual percepts in blind subjects.
Primary Outcome Measure Information:
Title
Number of Adverse Events From 2 Weeks Post-op Until the End of the Study
Description
All adverse events are collected as a result of chronic electrical stimulation and/or surgical complications.
Time Frame
From 2 weeks post-op until end of device usage, up to 10 years.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Confirmed history of retinal degenerative disease in the worse seeing eye with remaining vision no better than light perception. The fellow eye can have any visual acuity but must have better vision than the eye that will have the surgery. History of former useful form vision in worse-seeing eye Acceptable ability to describe visual percepts Age eighteen (18) or older Exclusion Criteria: History of glaucoma Optic neuropathy or other confirmed damage to optic nerve or visual cortical damage Presence of communicable disease/infection Pregnancy History of claustrophobia Inconsistent flash detection thresholds Any other diseases that can effect the function of the retina Subjects with a Beck Depression Inventory Interpretation score of >30 and subsequent diagnosis of depression by a psychiatrist. Corneal degeneration
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lisa Olmos, MD
Organizational Affiliation
Doheny Eye Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Doheny Eye Institute
City
Los Angeles
State/Province
California
ZIP/Postal Code
90033
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32131056
Citation
Yue L, Wuyyuru V, Gonzalez-Calle A, Dorn JD, Humayun MS. Retina-electrode interface properties and vision restoration by two generations of retinal prostheses in one patient-one in each eye. J Neural Eng. 2020 Apr 9;17(2):026020. doi: 10.1088/1741-2552/ab7c8f.
Results Reference
derived
PubMed Identifier
22110084
Citation
Nanduri D, Fine I, Horsager A, Boynton GM, Humayun MS, Greenberg RJ, Weiland JD. Frequency and amplitude modulation have different effects on the percepts elicited by retinal stimulation. Invest Ophthalmol Vis Sci. 2012 Jan 20;53(1):205-14. doi: 10.1167/iovs.11-8401.
Results Reference
derived
PubMed Identifier
21296811
Citation
Eng JG, Agrawal RN, Tozer KR, Ross-Cisneros FN, Dagnelie G, Greenberg RJ, Chader GJ, Weiland JD, Rao NA, Sadun AA, Humayun MS. Morphometric analysis of optic nerves and retina from an end-stage retinitis pigmentosa patient with an implanted active epiretinal array. Invest Ophthalmol Vis Sci. 2011 Jun 28;52(7):4610-6. doi: 10.1167/iovs.09-4936.
Results Reference
derived
PubMed Identifier
20720224
Citation
Horsager A, Boynton GM, Greenberg RJ, Fine I. Temporal interactions during paired-electrode stimulation in two retinal prosthesis subjects. Invest Ophthalmol Vis Sci. 2011 Feb 1;52(1):549-57. doi: 10.1167/iovs.10-5282. Print 2011 Jan.
Results Reference
derived
PubMed Identifier
19608533
Citation
Greenwald SH, Horsager A, Humayun MS, Greenberg RJ, McMahon MJ, Fine I. Brightness as a function of current amplitude in human retinal electrical stimulation. Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5017-25. doi: 10.1167/iovs.08-2897. Epub 2009 Jul 15.
Results Reference
derived
PubMed Identifier
19365014
Citation
Caspi A, Dorn JD, McClure KH, Humayun MS, Greenberg RJ, McMahon MJ. Feasibility study of a retinal prosthesis: spatial vision with a 16-electrode implant. Arch Ophthalmol. 2009 Apr;127(4):398-401. doi: 10.1001/archophthalmol.2009.20.
Results Reference
derived
PubMed Identifier
19098313
Citation
Horsager A, Greenwald SH, Weiland JD, Humayun MS, Greenberg RJ, McMahon MJ, Boynton GM, Fine I. Predicting visual sensitivity in retinal prosthesis patients. Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1483-91. doi: 10.1167/iovs.08-2595. Epub 2008 Dec 20.
Results Reference
derived
PubMed Identifier
18515576
Citation
de Balthasar C, Patel S, Roy A, Freda R, Greenwald S, Horsager A, Mahadevappa M, Yanai D, McMahon MJ, Humayun MS, Greenberg RJ, Weiland JD, Fine I. Factors affecting perceptual thresholds in epiretinal prostheses. Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2303-14. doi: 10.1167/iovs.07-0696.
Results Reference
derived

Learn more about this trial

Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa

We'll reach out to this number within 24 hrs